Skip to main content
. 2020 Oct 26;56(6):106214. doi: 10.1016/j.ijantimicag.2020.106214

Table 8.

Summary of adverse events in the treatment group

Event Patients [n (%) of N = 141]
Any adverse event 67 (48)
Weakness 30 (21)
Nausea 20 (14)
Diarrhoea 15 (11)
Rash 2 (1)